Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Atresia | 1 | 2009 | 2 | 0.310 |
Why?
|
| Epoprostenol | 1 | 2009 | 15 | 0.300 |
Why?
|
| Hypertension, Pulmonary | 1 | 2009 | 97 | 0.280 |
Why?
|
| Pneumonia, Ventilator-Associated | 3 | 2013 | 37 | 0.280 |
Why?
|
| Antihypertensive Agents | 1 | 2009 | 172 | 0.280 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 132 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 154 | 0.110 |
Why?
|
| Cross Infection | 2 | 2013 | 167 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2017 | 340 | 0.110 |
Why?
|
| Intubation, Intratracheal | 2 | 2013 | 203 | 0.100 |
Why?
|
| Tracheitis | 1 | 2013 | 1 | 0.100 |
Why?
|
| Bronchitis | 1 | 2013 | 30 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 58 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2012 | 153 | 0.090 |
Why?
|
| Infection Control | 1 | 2012 | 105 | 0.080 |
Why?
|
| Edema | 1 | 2009 | 42 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 176 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 299 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2009 | 117 | 0.070 |
Why?
|
| Dyspnea | 1 | 2009 | 124 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 186 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2009 | 159 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 869 | 0.070 |
Why?
|
| Cardiac Catheterization | 1 | 2009 | 292 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 800 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 5691 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 2480 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2009 | 2047 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 1669 | 0.040 |
Why?
|
| Emergency Treatment | 1 | 2017 | 58 | 0.030 |
Why?
|
| Video Recording | 1 | 2017 | 139 | 0.030 |
Why?
|
| Female | 3 | 2017 | 33360 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 744 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 3724 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 486 | 0.030 |
Why?
|
| Humans | 5 | 2017 | 64252 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1162 | 0.030 |
Why?
|
| APACHE | 1 | 2013 | 43 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 214 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 5339 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 412 | 0.020 |
Why?
|
| Synbiotics | 1 | 2012 | 5 | 0.020 |
Why?
|
| Oral Hygiene | 1 | 2012 | 13 | 0.020 |
Why?
|
| Hand Disinfection | 1 | 2012 | 18 | 0.020 |
Why?
|
| Middle Aged | 1 | 2009 | 17906 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2012 | 19 | 0.020 |
Why?
|
| Ventilator Weaning | 1 | 2012 | 20 | 0.020 |
Why?
|
| Gastrointestinal Agents | 1 | 2012 | 26 | 0.020 |
Why?
|
| Disinfectants | 1 | 2012 | 26 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 209 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 108 | 0.020 |
Why?
|
| Patient Positioning | 1 | 2012 | 50 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2012 | 177 | 0.020 |
Why?
|
| Inservice Training | 1 | 2012 | 87 | 0.020 |
Why?
|
| Probiotics | 1 | 2012 | 48 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 150 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 155 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 318 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 462 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2013 | 414 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1118 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 3316 | 0.020 |
Why?
|
| Critical Illness | 1 | 2012 | 327 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1383 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 14657 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1176 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1569 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 818 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1561 | 0.020 |
Why?
|
| Male | 2 | 2017 | 30305 | 0.010 |
Why?
|